Schedule 13G Filing for Reviva Pharmaceuticals Holdings, Inc.

This filing reports that as of March 23, 2026, Integrated Core Strategies (US) LLC beneficially owns 6.2% of Reviva Pharmaceuticals Holdings, Inc. common stock, amounting to 793,952 shares. This ownership is held with shared voting and dispositive power. The filing also notes that Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander are involved in a joint filing agreement with Integrated Core Strategies (US) LLC. These entities share voting and dispositive power over the securities. The filing certifies that the securities were not acquired or held for the purpose of influencing the control of the issuer.